Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Palvella Therapeutics, Inc. PVLA

Set alert

Price alert · PVLA

All alert types
151.82 USD +5.49 +3.75%

As of Nov 3, 3:12 PM ET

Bid
151.72 × 1
Ask
152.35 × 1
142.89 Day range 153.23
75.06 52-week range 158.13
YTD
+45.05%
1 year
+97.58%
Open
147.14
Prev close
146.33
Mkt cap
2.19B
Vol
204.89K
Avg vol
216.63K
EPS
-4.85
P/E
0.00
Div yield
0.00%
More statistics
Low
142.89
High
153.23
Forward P/E
-18.51
Beta
0.00
Short ratio
9.92
Inst. own
105.05%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
141.47
200-d avg
126.93
1y target
228.40

5D chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Oct 28, 2026Rating: Chardan Capital · Buy → Buy
Signals (103)
NameTimeAgo
SMA: BullishNov 3, 9:30 AM5 hours ago
SMA: BearishNov 2, 3:55 PM23 hours ago
SMA: BullishNov 2, 3:35 PM23 hours ago
SMA: BearishNov 2, 3:25 PM23 hours ago
SMA: BullishNov 2, 2:55 PM1 day ago
SMA: BullishNov 2, 2:55 PM1 day ago
MACD: Buy SignalNov 2, 2:55 PM1 day ago
SMA: BearishNov 2, 2:45 PM1 day ago
SMA: BullishNov 2, 2:30 PM1 day ago
SMA: BearishNov 2, 2:15 PM1 day ago
SMA: BullishNov 2, 2:10 PM1 day ago
SMA: BearishNov 2, 1:40 PM1 day ago
SMA: BearishNov 2, 1:40 PM1 day ago
MACD: Sell SignalNov 2, 1:40 PM1 day ago
MACD: Buy SignalNov 2, 1:20 PM1 day ago
MACD: Sell SignalNov 2, 1:15 PM1 day ago
SMA: BullishNov 2, 12:50 PM1 day ago
SMA: BearishNov 2, 12:10 PM1 day ago
SMA: BullishNov 2, 11:35 AM1 day ago
MACD: Buy SignalNov 2, 11:35 AM1 day ago

Newest 20 of 103.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 228.40 +50.4% upside
Target (low)
205.00
Target (mean)
228.40
Target (high)
267.00
Ratings (0m) 16 16 buy · 0 hold · 0 sell
  • Strong buy0
  • Buy16
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 16
  • 1 month ago 15
  • 2 months ago 15

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

PVLA analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-1.73-2.31 – -1.05-1.03-68.1%00.0%13
Next quarter-2.04-2.73 – -1.21-1.08-89.1%00.0%13
Current year-6.39-7.84 – -3.95-3.71-72.2%00.0%13
Next year-7.91-13.52 – -1.54-6.39-23.8%24.63M0.0%11

Upgrades and downgrades

The latest rating changes

PVLA analyst upgrades and downgrades
DateFirmActionFromTo
Oct 28, 2026Chardan CapitalMaintainedBuyBuy
Oct 16, 2026William BlairInitiated—Outperform
Oct 12, 2026HC Wainwright & Co.MaintainedBuyBuy
Sep 21, 2026Chardan CapitalMaintainedBuyBuy
May 21, 2026Stephens & Co.ReiteratedOverweightOverweight
May 21, 2026Chardan CapitalMaintainedBuyBuy
May 12, 2026Stephens & Co.Initiated—Overweight
Mar 31, 2026Chardan CapitalMaintainedBuyBuy
Mar 24, 2026HC Wainwright & Co.MaintainedBuyBuy
Mar 16, 2026Chardan CapitalMaintainedBuyBuy
Feb 25, 2026MizuhoMaintainedOutperformOutperform
Feb 25, 2026BTIGMaintainedBuyBuy
Feb 24, 2026Chardan CapitalMaintainedBuyBuy
Feb 24, 2026HC Wainwright & Co.MaintainedBuyBuy
Jan 29, 2026BTIGReiteratedBuyBuy
Jan 16, 2026BTIGReiteratedBuyBuy
Jan 7, 2026MizuhoInitiated—Outperform
Dec 16, 2025Truist SecuritiesMaintainedBuyBuy
Dec 16, 2025Canaccord GenuityMaintainedBuyBuy
Dec 16, 2025TD CowenMaintainedBuyBuy
Dec 16, 2025Chardan CapitalMaintainedBuyBuy
Dec 15, 2025HC Wainwright & Co.MaintainedBuyBuy
Dec 15, 2025BTIGMaintainedBuyBuy
Dec 5, 2025Clear StreetInitiated—Buy
Dec 5, 2025BTIGInitiated—Buy
Dec 4, 2025Craig-HallumInitiated—Buy
Nov 24, 2025StifelMaintainedBuyBuy
Nov 19, 2025Raymond JamesUpgradeOutperformStrong Buy
Nov 13, 2025Canaccord GenuityMaintainedBuyBuy
Nov 13, 2025Chardan CapitalMaintainedBuyBuy